The registry of COVID-19 patients was designed to collect epidemiolgical, demographic, clinical, anamnestic and outcome information together with serological and microbiological samples from COVID-19 patients admitted at the University Hospital of Verona (Azienda Ospedaliera Universitaria Integrata, AOUI Verona). All SARS-CoV 2 positive patients admitted and able to give an informed consent are included, irrespectively of age and gender.
Anamnestic data are collected at the enrollment, while all the other clinical and epidemiological information are retrieved retrospectively from patients' medical records and electronic health records. Serological and microbiological samples (blood samples, fecal samples and nasal/rectal swabs) are collected within 48 hours after admission and during the hospital stay, according with routine internal procedures.The biological samples are stored at the University Laboratory for Medical Research (Laboratorio Universitario di Ricerca Medica, LURM). A dedicated database has been created and implemented to collect all the above mentioned information.
Study Type
OBSERVATIONAL
Enrollment
430
not applicable (observational study)
University Hospital of Verona
Verona, Italy
Epidemiological predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona
Epidemiological data including demographic data, contact with COVD-19 positive patients and onset of symptoms.
Time frame: through study completion, an average of 3 months
Clinical predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona
Underlying chronic diseases, signs/symptoms related with COVID-19 diseases an clinical presentation on admission
Time frame: through study completion, an average of 3 months
Body temperature (°C) on admission in COVID-19 patients admitted to University Hospital of Verona
Body temperature (°C)
Time frame: through study completion, an average of 3 months
Blood pressure (mmHg) on admission in COVID-19 patients admitted to University Hospital of Verona
Blood pressure (mmHg)
Time frame: through study completion, an average of 3 months
Pulse rate (beats per minute) on admission in COVID-19 patients admitted to University Hospital of Verona
Pulse rate (beats per minute)
Time frame: through study completion, an average of 3 months
Respiratory rate (breaths per minute) on admission in COVID-19 patients admitted to University Hospital of Verona
Pulse rate (beats per minute)
Time frame: through study completion, an average of 3 months
Peripheral oxygen saturation (%) on admission in COVID-19 patients admitted to University Hospital of Verona
Peripheral oxygen saturation (%)
Time frame: through study completion, an average of 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
C reactive protein (CRP, m/gL) in COVID-19 patients admitted to University Hospital of Verona
CRP (m/gL)
Time frame: through study completion, an average of 3 months
Procalcitonin (PCT, ng/mL) in COVID-19 patients admitted to University Hospital of Verona
PCT (ng/mL
Time frame: through study completion, an average of 3 months
White Blood Count (WBC, cell/mm3) in COVID-19 patients admitted to University Hospital of Verona
White Blood Count (WBC, cell/mm3)
Time frame: through study completion, an average of 3 months
Neutrophils (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona
Neutrophils (cell/mm3)
Time frame: through study completion, an average of 3 months
Lymphocytes (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona
Lymphocytes (cell/mm3)
Time frame: through study completion, an average of 3 months
Platelets (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona
Platelets (cell/mm3)
Time frame: through study completion, an average of 3 months
L-lattato deidrogenasi (LDH, mU/ml) in COVID-19 patients admitted to University Hospital of Verona
LDH (mU/ml)
Time frame: through study completion, an average of 3 months
Creatine kinase (CK, U/L) in COVID-19 patients admitted to University Hospital of Verona
CK (U/L)
Time frame: through study completion, an average of 3 months
D-dimer (μg/L) in COVID-19 patients admitted to University Hospital of Verona
D-dimer (μg/L)
Time frame: through study completion, an average of 3 months
fibrinogen (g/L) in COVID-19 patients admitted to University Hospital of Verona
fibrinogen (g/L)
Time frame: through study completion, an average of 3 months
ferritin (mcg/L) in COVID-19 patients admitted to University Hospital of Verona
ferritin (mcg/L)
Time frame: through study completion, an average of 3 months
AST (U/L) in COVID-19 patients admitted to University Hospital of Verona
AST (U/L)
Time frame: through study completion, an average of 3 months
ALT (U/L) in COVID-19 patients admitted to University Hospital of Verona
ALT (U/L)
Time frame: through study completion, an average of 3 months
Creatinine (mg/dl) in COVID-19 patients admitted to University Hospital of Verona
Creatinine (mg/dl)
Time frame: through study completion, an average of 3 months
Arterial blood gas anaysis pH in COVID-19 patients admitted to University Hospital of Verona
pH
Time frame: through study completion, an average of 3 months
Arterial blood gas anaysis pO2 (mmHg) in COVID-19 patients admitted to University Hospital of Verona
pO2 (mmHg)
Time frame: through study completion, an average of 3 months
Arterial blood gas anaysis pCO2 (mmHg) in COVID-19 patients admitted to University Hospital of Verona
pCO2 (mmHg)
Time frame: through study completion, an average of 3 months
Arterial blood gas anaysis HCO3 (mmol/l) in COVID-19 patients admitted to University Hospital of Verona
HCO3 (mmol/l)
Time frame: through study completion, an average of 3 months
Arterial blood gas anaysis SpO2 (%) in COVID-19 patients admitted to University Hospital of Verona
SpO2 (%)
Time frame: through study completion, an average of 3 months
Host-related factors associated with the pathogenesis of COVID-19
IL-6 (pg/mL)
Time frame: through study completion, an average of 3 months
Virological factors associated with the pathogenesis of COVID-19
Nasal and rectal swabs, fecal samples and blood samples
Time frame: through study completion, an average of 3 months